Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Orvacabtagene autoleucel

Name: The impact of daratumumab refractoriness on clinical outcomes following CAR-T in R/R myeloma
Uploaded: 2024-10-28T00:00:00Z
Duration: 2 min 36 s

Sorry, no posts matched your criteria.

Orvacabtagene autoleucel

Cookie settings